Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution
- First Online:
- 102 Downloads
We prospectively evaluated the prevalence and predictors of complementary medicine (CAM) use among Japanese patients with urologic cancer 1 year after diagnosis.
Patients and methods
A total of 349 patients with newly diagnosed urologic cancer answered a self-administered questionnaire on CAM use 1 year after diagnosis. General-health-related quality of life (GHQL) of the patients was also assessed at diagnosis and 1 year after diagnosis using the Medical Outcome Study Short Form-36 (SF-36). The overall prevalence, types of CAM used, and costs of CAM were assessed. The effects of several variables including GHQL at baseline and 1 year after treatment on the prevalence of use of CAM were evaluated.
A total of 164 respondents (47%) admitted using some type of CAM, of which 73 (45%) had used multiple types. “Health food,” in particular extract from Agaricus blazei, was the most common type of CAM used. CAM users had significantly lower scores for social function, general health perception, and vitality domains than CAM non-users 1 year after diagnosis. This tendency was more marked in users of multiple types of CAM.
“Health food,” including extract from A. blazei, was the most commonly used CAM in Japan. The prevalence of CAM use did not differ between patients with prostate cancer and those with urologic cancer other than prostrate cancer. CAM users, especially those who used multiple types of CAM, had lower GHQL scores than non-users of CAM.
KeywordsUrologic cancer Alternative medicine Health survey General-health-related quality of life Epidemiology
- 2.Lippert MC, McClain R, Boyd JC et al (1999) Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer 86:2642–2648Google Scholar
- 3.Kao GD, Devine P (2000) Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer 88:615–619Google Scholar
- 8.Ponholzer A, Struhal G, Madersbacher S (2003) Frequent use of complementary medicine by prostate cancer patients. Eur Urol 43:604–608Google Scholar
- 14.Liu JM, Chu HC, Chin YH et al (1997) Cross sectional study of use of alternative medicines in Chinese cancer patients. Jpn J Clin Oncol 27:37–41Google Scholar
- 19.Rees RW, Feigel I, Vickers A et al (2000) Prevalence of complementary therapy use by women with breast cancer: a population-based study. Eur J Cancer 36:1359–1364Google Scholar
- 21.Mochen R, Kemmler G, Schweigkofler H et al (2001) Use of alternative/complementary therapy in breast cancer patients—a psychological perspective. Support Care Cancer 9:267–274Google Scholar
- 25.Davidson R, Geoghegan L, McLaughlin L et al Psychological characteristics of cancer patients who use complementary therapies. Psycho Oncol, (in print)Google Scholar